128 related articles for article (PubMed ID: 2240160)
1. Metaplastic change in mesenchymal stem cells induced by activated ras oncogene.
Tzen CY; Filipak M; Scott RE
Am J Pathol; 1990 Nov; 137(5):1091-102. PubMed ID: 2240160
[TBL] [Abstract][Full Text] [Related]
2. Differentiation can convey resistance to transformation by activated ras oncogene.
Tzen CY; Maercklein PB; Scott RE
Anticancer Res; 1990; 10(5A):1329-34. PubMed ID: 2241110
[TBL] [Abstract][Full Text] [Related]
3. Differentiation, dedifferentiation, and transdifferentiation of BALB/c 3T3 T mesenchymal stem cells: potential significance in metaplasia and neoplasia.
Sparks RL; Seibel-Ross EI; Wier ML; Scott RE
Cancer Res; 1986 Oct; 46(10):5312-9. PubMed ID: 3756880
[TBL] [Abstract][Full Text] [Related]
4. Loss of differentiation control in transformed 3T3 T proadipocytes.
Sparks RL; Allen BJ; Zygmunt AI; Strauss EE
Cancer Res; 1993 Apr; 53(8):1770-6. PubMed ID: 8467495
[TBL] [Abstract][Full Text] [Related]
5. Inhibited neoplastic phenotype by the c-Ha-ras antisense RNA.
Lu GR; Wu CJ; Ke Y; Xiong X; Li YJ; Liu JM; Xu Y; Xu W; Li JY; Deng GR
Sci China B; 1991 Dec; 34(12):1485-91. PubMed ID: 1801843
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility to ras oncogene transformation is coregulated with signal transduction through growth factor receptors.
Chiao PJ; Kannan P; Yim SO; Krizman DB; Wu TA; Gallick GE; Tainsky MA
Oncogene; 1991 May; 6(5):713-20. PubMed ID: 1646984
[TBL] [Abstract][Full Text] [Related]
7. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes.
Benito M; Porras A; Nebreda AR; Santos E
Science; 1991 Aug; 253(5019):565-8. PubMed ID: 1857988
[TBL] [Abstract][Full Text] [Related]
9. Correlation of growth capacity of cells in hard agarose with successful transfection by the activated c-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites.
Fidler IJ; Li LM; Ananthaswamy HN; Esumi N; Radinsky R; Price JE
Anticancer Res; 1991; 11(1):17-24. PubMed ID: 2018350
[TBL] [Abstract][Full Text] [Related]
10. Response of FR3T3 cells transformed by Ha-ras oncogene and epidermal growth factor gene to differentiation induction by N,N-dimethylformamide.
Levine AE; Chakrabarty S
Int J Cancer; 1992 Feb; 50(4):653-8. PubMed ID: 1537633
[TBL] [Abstract][Full Text] [Related]
11. Identification of the transformation-associated cell surface antigen expressed on the rat fetus-derived fibroblast.
Yagihashi A; Sato N; Torigoe T; Okubo M; Konno A; Takahashi N; Yamashita T; Fujinaga K; Kuzumaki N; Kikuchi K
Cancer Res; 1988 May; 48(10):2798-804. PubMed ID: 3162824
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
13. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
14. Definition of the activities and properties of c-myc required to inhibit cell differentiation.
Freytag SO; Dang CV; Lee WM
Cell Growth Differ; 1990 Jul; 1(7):339-43. PubMed ID: 2278885
[TBL] [Abstract][Full Text] [Related]
15. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
Wang B; Soule HD; Miller FR
Anticancer Res; 1997; 17(6D):4387-94. PubMed ID: 9494538
[TBL] [Abstract][Full Text] [Related]
16. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the human Harvey-ras oncogene expression by DNA methylation.
Borrello MG; Pierotti MA; Donghi R; Bongarzone I; Cattadori MR; Traversari C; Mondellini P; Della Porta G
Oncogene Res; 1988; 2(2):197-203. PubMed ID: 2464152
[TBL] [Abstract][Full Text] [Related]
18. EJ/ras neoplastic transformation of simian virus 40-immortalized human uroepithelial cells: a rare event.
Christian BJ; Kao CH; Wu SQ; Meisner LF; Reznikoff CA
Cancer Res; 1990 Aug; 50(15):4779-86. PubMed ID: 2164447
[TBL] [Abstract][Full Text] [Related]
19. Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells.
Pratt CI; Kao CH; Wu SQ; Gilchrist KW; Oyasu R; Reznikoff CA
Cancer Res; 1992 Feb; 52(3):688-95. PubMed ID: 1310069
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
